SecBot SecBot
8-K ·Filed Feb 27, 2026

TMDX

TransMedics Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC0001193125-26-079392
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

Investors should focus on the adjusted net income of $17.5 million as a better indicator of ongoing profitability. The one-time tax benefit is not repeatable, so future quarters will likely show lower net income unless operational performance improves. Monitor future guidance for any changes in revenue or expense outlook.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$145.26
T+0 close · Feb 27, 2026 · via day close
Latest settled
−51.49%
T+60 · $70.46
Vs SPY
−60.88%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 27 $145.26entry
  2. T+1 · 9mo ago +1.20%α +1.14% · $147.00
  3. T+5 · 9mo ago −10.77%α −8.79% · $129.61
  4. T+20 · 8mo ago −31.81%α −24.26% · $99.05
  5. T+60 · 6mo ago −51.49%α −60.88% · $70.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

TransMedics provided additional details on its Q4 2025 financial results, clarifying that the previously reported $105.4 million net income included a one-time $83.8 million tax benefit from releasing a $103.3 million U.S. valuation allowance. Adjusted net income for the quarter was $17.5 million. The company reaffirmed its expectation of future tax provisions aligning with statutory rates.

Key Financial Metrics

Revenue
$160.8M
+32.0% YoY
Adj. EPS
$0.47
GAAP: $2.62
Guidance
$727M-$757M
maintained
Gross Margin
58%

Key Facts

  • TransMedics released a $103.3 million U.S. tax valuation allowance in Q4 2025, resulting in an $83.8 million net income tax benefit.
  • Reported Q4 2025 net income was $105.4 million; adjusted net income, excluding the tax benefit, was $17.5 million.
  • The annual effective tax rate for 2025 was (77.0)%, but would have been 19.1% without the valuation allowance release.
  • The company expects future quarterly tax provisions to be in line with U.S. statutory corporate income tax rates.

Financial Impact

The one-time tax benefit of $83.8 million inflated Q4 net income by $87.9 million compared to adjusted figures. The core business generated $17.5 million in net income.

net incomeepseffective tax rate

Risk Factors

  • The significant one-time tax benefit may lead to unrealistic expectations for future profitability.
  • The company has a material weakness in internal control over financial reporting, which could affect future financial statements.
  • Future financial performance is subject to risks including market acceptance of the OCS, regulatory developments, and ability to sustain profitability.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-079392
Document: d80286dex991.htm0001193125-26-079392
Document: 0001193125-26-079392-index-headers.html0001193125-26-079392
Document: 0001193125-26-079392-index.html0001193125-26-079392
Document: 0001193125-26-079392.txt0001193125-26-079392
CONTEXT: Previous Earnings (2026-02-24)0001193125-26-066953

Track record

9 reports on TMDX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 Now $92.21 +1.39% settles Nov 17
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
  3. Nov 5, 202611d ago Press Release Bullish 6/10 No price data
  4. Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
  5. Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
  6. Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
  7. Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
  8. Feb 27, 202637w ago 8-K Neutral 4/10 Viewing Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
  9. Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 6h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026